Cedars-Sinai Cancer Beverly Hills — Beverly Hills, California

Cedars-Sinai Cancer Beverly Hills is a clinical research site located in Beverly Hills, California, United States 90211.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Cedars-Sinai Cancer Beverly Hills has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.

Sponsors: Pfizer, BriaCell Therapeutics Corporation.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cedars-Sinai Cancer Beverly Hills?

Cedars-Sinai Cancer Beverly Hills has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cedars-Sinai Cancer Beverly Hills conducted?

Cedars-Sinai Cancer Beverly Hills has 3 clinical trials on record, with 3 currently active. Their work covers Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.

Is Cedars-Sinai Cancer Beverly Hills accredited by Crixeo Health?

Cedars-Sinai Cancer Beverly Hills has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cedars-Sinai Cancer Beverly Hills?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.